These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 921344)

  • 21. Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus.
    ter Borg EJ; Groen H; Horst G; Limburg PC; Wouda AA; Kallenberg CG
    Semin Arthritis Rheum; 1990 Dec; 20(3):164-73. PubMed ID: 2287941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of patients with serum antibodies to extractable nuclear antigens.
    Leibfarth JH; Persellin RH
    Arthritis Rheum; 1976; 19(5):851-6. PubMed ID: 786296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
    Lundberg I; Hedfors E
    J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed connective tissue disease in childhood. A clinical and serologic survey.
    Singsen BH; Bernstein BH; Kornreich HK; King KK; Hanson V; Tan EM
    J Pediatr; 1977 Jun; 90(6):893-900. PubMed ID: 300795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The correlation of antibodies to nuclear ribonucleoprotein (RNP) and nuclear acidic protein (Sm) with nephritis in patients with systemic lupus erythematosus (SLE).
    Kurata N; Hara I; Kinashi M; Akita H; Ofuji T
    Contrib Nephrol; 1978; 9():17-24. PubMed ID: 668385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human fibroblasts, a convenient nuclear substrate for detection of anti-nuclear antibodies including anti-centromere antibodies.
    Kallenberg CG; van der Meulen J; Pastoor GW; Snijder JA; Feltkamp TE; The TH
    Scand J Rheumatol; 1983; 12(3):193-200. PubMed ID: 6414079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sjogren's syndrome in SLE: Part I. The frequency of the clinical and subclinical features of Sjogren's syndrome in patients with SLE.
    Grennan DM; Ferguson M; Williamson J; Mavrikakis M; Dick WC; Buchanan WW
    N Z Med J; 1977 Oct; 86(598):374-6. PubMed ID: 272546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subsets of autoantibodies to extractable nuclear antigens (ENA) as assayed by ELISA correlate with specific clinical abnormalities in SLE.
    Warlow RS
    Scand J Rheumatol; 1986; 15(1):57-67. PubMed ID: 2421399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sjogren's syndrome in SLE: Part 2. An examination of the clinical significance of Sjogren's syndrome by comparison of its frequency in typical and atypical forms of SLE, overlap syndromes and scleroderma.
    Grennan DM; Ferguson M; Ghobarey AE; Williamson J; Dick WC; Buchanan WW
    N Z Med J; 1977 Oct; 86(598):376-9. PubMed ID: 272547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incidence and clinical significance of antibodies to extractable nuclear antigens.
    Hamburger M; Hodes S; Barland P
    Am J Med Sci; 1977; 273(1):21-8. PubMed ID: 300568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 33. The measurement of antibodies to extractable nuclear antigen.
    Dorsch CA; White GM; Berzofsky RN
    Am J Clin Pathol; 1979 Mar; 71(3):333-7. PubMed ID: 107791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases.
    Miyachi K; Tan EM
    Arthritis Rheum; 1979 Jan; 22(1):87-93. PubMed ID: 103560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
    Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
    Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and risk stratification in patients with anti-RNP autoimmunity.
    Carpintero MF; Martinez L; Fernandez I; Romero AC; Mejia C; Zang YJ; Hoffman RW; Greidinger EL
    Lupus; 2015 Sep; 24(10):1057-66. PubMed ID: 25736140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients.
    Furtado RN; Pucinelli ML; Cristo VV; Andrade LE; Sato EI
    Lupus; 2002; 11(1):35-41. PubMed ID: 11899953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Raynaud's phenomenon in primary Sjögren's syndrome.
    Skopouli FN; Talal A; Galanopoulou V; Tsampoulas CG; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1990 May; 17(5):618-20. PubMed ID: 2359071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
    Peltier AP; Gaudreau A; Amor B; Kahn MF; Ryckewaert A; Sany J; Haim T
    Nouv Presse Med; 1978 May; 7(21):1813-8. PubMed ID: 307737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.